Composite

Part:BBa_K5207021

Designed by: Ruyi Shi   Group: iGEM24_Shanghai-BioX   (2024-09-30)
Revision as of 13:11, 1 October 2024 by Lucyshi2018 (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


DS-CarnosicAcid

This composite part consists of six expression cassettes, expressing SmGGPPS, SmCPS1, SmKSL, SmCPR, CYP76AH22, and CYP76AK6.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 4456
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 685
    Illegal BglII site found at 3217
    Illegal BglII site found at 6298
    Illegal BglII site found at 9089
    Illegal BamHI site found at 2815
    Illegal XhoI site found at 2951
    Illegal XhoI site found at 2975
    Illegal XhoI site found at 4268
    Illegal XhoI site found at 4478
    Illegal XhoI site found at 4950
    Illegal XhoI site found at 8131
    Illegal XhoI site found at 11232
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 2620
    Illegal NgoMIV site found at 4037
    Illegal NgoMIV site found at 4601
    Illegal NgoMIV site found at 8578
    Illegal AgeI site found at 861
    Illegal AgeI site found at 11195
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 5196
    Illegal BsaI site found at 8117
    Illegal BsaI site found at 8378
    Illegal BsaI.rc site found at 6308
    Illegal BsaI.rc site found at 8367
    Illegal BsaI.rc site found at 9099
    Illegal BsaI.rc site found at 11477
    Illegal SapI.rc site found at 12576


Usage and Biology

To realize the production of carnosic acid, the active ingredients of Salvia plants, on the yeast platform, we planned to integrate various key enzyme genes, SmGGPPS, SmCPS, SmKSL, SmCPR, CYP76AH22, and CYP76AK6, respectively, into pYTK096 vector, and to select the corresponding genes for transcription and termination to control the expression of these enzymes in Saccharomyces cerevisiae.

As shown in the following figure: we constructed the plasmid vectors of TY10 by three steps (1) Level 0: cloning the sequences containing the target genes by PCR reaction, and inserting them into vector pYTK001 by BsmBI respectively, (2) Level 1: combining the modules of each Level 0, constructing them into vector pYTK095 after ligating them by BsaI zymography, (3) Level 2: Combination of individual Level 1 vectors, constructed into vector pYTK096 after ligation by BsmBI digestion.

Figure 1 Flowchart for Level-0 to Level-2 assembly

We combined the Level 1 vectors and constructed them into pYTK096 vector by BsmBI digestion and ligation, and successfully constructed the Level 2 vector. After transformation in E. coli DH10B identified positive monoclones by resistance, fluorescent labeling screening, and colony PCR. We can see that the one that does not show green fluorescence is the recombinant plasmid we want, which corresponds to the colony PCR agar gel image, and the recombinant plasmid is successfully constructed. Next, we extracted the corresponding plasmid DNA after amplification and culture, and used it for transformation in yeast cells.

Figure 2 (a) Fluorescent labeling screening of pYTK095, (b) Validation plot of pYTK096 gel electrophoresis

The constructed vector was linearized by NotI endonuclease and then transferred into BY4742 yeast receptor cells, which were screened by ura-deficient medium, and the yeast genomic DNA was extracted for PCR identification to determine the positive single clones. The validation results were shown in Figure 3, which worked as expected.


Figure 3 (a) Graph of the results of the screening of URA-deficient media of TY 9, (b) Gel validation of TY9 and TY10 recombinant plasmids in yeast cells

Product Analysis

The successful monoclonal plasmid was expanded in culture, shaken small overnight and preserved, and the strain was further fermented and cultured using liquid YPDA medium for 5 days and then centrifuged to collect the organisms.


Figure 4 Schematic diagram of the fermented bacterial liquid


Saccharomyces cerevisiae cells were extracted with methanol by Ultrasonic Cell Disruption for 1 h. After centrifugation at low temperature, the supernatant extract was filtered with a filter membrane, and the filtered samples were transferred to liquid phase vials with lined tubes for Q-Exactive analysis, and the results were as follows:

Figure 5 Chromatogram of S. c BY4742/TY10 extract (A), carnosic acid (CA) standard (B), and carnosol (CV) standard (C); (D) CA and (E) CV standard curves.

The successful monoclonal plasmid was expanded in culture, shaken small overnight and preserved, and the strain was further fermented and cultured using liquid YPDA medium for 5 days and then centrifuged to collect the organisms.

As can be seen in Figure 5(A-C), CV and CA confirmed the correct synthesis of the products by the mass-to-charge ratios and intensities of the absorption peaks where they are located and the molecular masses compared to the standards. In Figure 5 (D-E), we used CV and CA standards and their corresponding peak areas to derive the corresponding equations: Equation for CA: y=2E+0.6x+1356.6 (R^2=0.9997) Equation for CV: 1E+0.6x+1252.5 (R^2=0.9993)

The yield of CA in the test was calculated to be 0.268 mg/ml, and similarly, the yield of CV in the test can be obtained to be 0.857 mg/ml. Further, the content of the extracted CA in 3 L of fermentation broth in the experiment was obtained to be 0.178 mg/L, and the content of CV was obtained to be 0.571 mg/L.

In summary, we successfully synthesized key bioactive compounds, carnosic acid, using Saccharomyces cerevisiae as a platform.

[edit]
Categories
Parameters
None